Latest articles

Life sciences logistics facilities, crucial for pharmaceutical distribution, are attracting institutional investors like never before.

To maximise the value of their enormous real estate portfolios, pharma companies have two key strategies: continuous portfolio optimisation and capital unlocking through sale and leaseback (S&LB) transactions.

Adaptive reuse is a recurring theme in life sciences real estate and in this article, we turn our attention to

European life sciences incubators provide flexible spaces, specialised equipment, and essential support services; they also foster innovation through strong academic and industry connections, funding opportunities, and collaborative environments.

Sustainability initiatives in life sciences buildings focus on energy, water and embodied carbon

Real estate investors like having medtech companies as tenants.